"Interferon Type I" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA).
Descriptor ID |
D007370
|
MeSH Number(s) |
D12.644.276.374.440.890 D12.776.467.374.440.890 D23.529.374.440.890
|
Concept/Terms |
Interferon Type I- Interferon Type I
- Type I Interferons
- Interferons, Type I
- Interferons Type I
- Type I Interferon
- Interferon, Type I
|
Below are MeSH descriptors whose meaning is more general than "Interferon Type I".
Below are MeSH descriptors whose meaning is more specific than "Interferon Type I".
This graph shows the total number of publications written about "Interferon Type I" by people in this website by year, and whether "Interferon Type I" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 7 | 0 | 7 |
1996 | 2 | 1 | 3 |
1997 | 3 | 1 | 4 |
1998 | 2 | 1 | 3 |
1999 | 4 | 0 | 4 |
2000 | 3 | 1 | 4 |
2001 | 1 | 0 | 1 |
2002 | 2 | 0 | 2 |
2004 | 1 | 0 | 1 |
2005 | 3 | 1 | 4 |
2006 | 2 | 1 | 3 |
2007 | 1 | 1 | 2 |
2008 | 1 | 3 | 4 |
2009 | 2 | 0 | 2 |
2010 | 3 | 3 | 6 |
2011 | 1 | 1 | 2 |
2012 | 5 | 1 | 6 |
2013 | 3 | 0 | 3 |
2014 | 3 | 1 | 4 |
2015 | 3 | 2 | 5 |
2016 | 3 | 4 | 7 |
2017 | 1 | 1 | 2 |
2018 | 0 | 5 | 5 |
2019 | 1 | 2 | 3 |
2020 | 2 | 0 | 2 |
2021 | 3 | 2 | 5 |
2022 | 4 | 0 | 4 |
2023 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interferon Type I" by people in Profiles.
-
Autoantibodies against type I IFNs in humans with alternative NF-?B pathway deficiency. Nature. 2023 Nov; 623(7988):803-813.
-
Blockade of interferon signaling decreases gut barrier integrity and promotes severe West Nile virus disease. Nat Commun. 2023 09 25; 14(1):5973.
-
CRAT links cholesterol metabolism to innate immune responses in the heart. Nat Metab. 2023 08; 5(8):1382-1394.
-
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ~40% of patients. J Exp Med. 2023 09 04; 220(9).
-
NFKB2 haploinsufficiency identified via screening for IFN-a2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications. J Allergy Clin Immunol. 2023 04; 151(4):926-930.e2.
-
Regulation and function of Id2 in plasmacytoid dendritic cells. Mol Immunol. 2022 08; 148:6-17.
-
Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid ? plaques. Immunity. 2022 05 10; 55(5):879-894.e6.
-
The bacterial microbiota regulates normal hematopoiesis via metabolite-induced type 1 interferon signaling. Blood Adv. 2022 03 22; 6(6):1754-1765.
-
HSCT corrects primary immunodeficiency and immune dysregulation in patients with POMP-related autoinflammatory disease. Blood. 2021 11 11; 138(19):1896-1901.
-
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Cell. 2021 10 14; 184(21):5338-5356.e21.